ISGLT2 in Patients Without DM With Acute MI

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Coronary SyndromesHeart Failure
Interventions
DRUG

With ISGLT2

Patients for whom we will prescribe ISGLT2

Trial Locations (1)

Unknown

Mohammed VI university hospital oujda, OUDA

All Listed Sponsors
lead

Mohammed VI University Hospital

OTHER

NCT06903754 - ISGLT2 in Patients Without DM With Acute MI | Biotech Hunter | Biotech Hunter